We are live on ! Find out more
UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Portfolio holdings

AUM $863M
1-Year Est. Return 30.35%
This Fund
S&P 500
This Quarter Est. Return
+3.77%
1 Year Est. Return
+30.35%
3 Year Est. Return
+68.34%
5 Year Est. Return
+24.17%
10 Year Est. Return
–
AUM
$259M
AUM Growth
-$1.67M
Cap. Flow
-$8.8M
Cap. Flow %
-3.4%
Top 10 Hldgs %
99.95%
Holding
26
New
7
Increased
–
Reduced
2
Closed
8

Top Buys

Rank Stock Value
1
DNLI icon
Denali Therapeutics
DNLI
+$1.03M
2
MNDY icon
monday.com
MNDY
+$110K
3
MA icon
Mastercard
MA
+$6.75K
4
V icon
Visa
V
+$6.64K
5
ADBE icon
Adobe
ADBE
+$5.64K

Top Sells

Rank Stock Value
1
BBRE icon
JPMorgan BetaBuilders MSCI US REIT ETF
BBRE
+$7.73M
2
BEAM icon
Beam Therapeutics
BEAM
+$1.83M
3
APEN
Apollo Endosurgery, Inc.
APEN
+$155K
4
CDAK
Codiak BioSciences, Inc. Common Stock
CDAK
+$148K
5
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$41.6K

Sector Composition

Rank Sector Weight
1 Healthcare 3.61%
2 Technology 3.13%
3 Financials 0.01%
4 Utilities 0%
5 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APEN
26
DELISTED
Apollo Endosurgery, Inc.
APEN
– –
-15,601
Closed -$155K
1
2

Similar funds

WFAL
Wedbush Fund Advisers, LLC Pasadena, California $863M AUM
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
OMG
One Madison Group New York $866M AUM 33.81% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
RWM
RMG Wealth Management Platteville, Wisconsin $866M AUM 11.95% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
HP
Havemeyer Place Greenwich, Connecticut $867M AUM
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s Q2 2023 Portfolio in Review

As of Q2 2023, University of Texas/Texas AM Investment Management Co (UTIMCO) held 26 positions worth $259M, down 0.64% from $260M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

University of Texas/Texas AM Investment Management Co (UTIMCO) withdrew a net $8.8M in Q2 2023, closing 8 positions and reducing 2 holdings. Its most notable exit was Beam Therapeutics, an estimated $1.83M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.6% of assets, up from 2.7% a quarter earlier, followed by Technology and Financials.

Against the trend, University of Texas/Texas AM Investment Management Co (UTIMCO) opened a new position in Denali Therapeutics worth $1.08M.

  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s largest Q2 2023 buy was Denali Therapeutics: 36,513 shares worth $1.08M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s biggest Q2 2023 reduction was JPMorgan BetaBuilders MSCI US REIT ETF, cutting an estimated $7.73M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) fully exited Beam Therapeutics in Q2 2023, selling an estimated $1.83M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s ten largest holdings make up 100% of its $259M portfolio in Q2 2023.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) opened 7 new positions and closed 8 in Q2 2023.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio value fell 0.64% quarter-over-quarter to $259M.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q2 2023, filed 4 Aug 2023.